Merck & Co., Inc. Sees Significant Institutional Investment Amid Keytruda Pipeline Growth
Talon Private Wealth LLC has acquired a new position in Merck & Co., Inc. (NYSE:MRK), according to the company's most recent Form 13F filing with the Securities & Exchange Commission.
The fund purchased 7,741 shares of the company's stock, valued at approximately $995,000 during the second quarter.
This acquisition is just one of many transactions involving Merck & Co., Inc. in recent quarters.
California State Teachers Retirement System, for example, increased its position in Merck & Co., Inc. by 12,537.4% in the second quarter and now owns 484,720,247 shares worth $62,286,552,000 after buying an additional 480,884,635 shares.
BlackRock Inc. also lifted its position in shares of Merck & Co., Inc. by 0.5% during the 2nd quarter and now owns 226,999,837 shares valued at $29,169,479,000 after buying an additional 1,073,507 shares.
Other hedge funds and institutional investors have also made significant transactions involving Merck & Co., Inc. in recent periods.